Specify a stock or a cryptocurrency in the search bar to get a summary
AusCann Group Holdings Ltd
ACNNFAusCann Group Holdings Ltd engages in the development and commercialization of cannabinoid-derived therapeutic products for humans and animals in Australia and internationally. Its principal product includes the novel tetrahydrocannabinol and cannabidiol (THC/CBD), a powder-based hard-shell capsules based on AusCann's Neuvis platform for the treatment of pain and related indications. The company is also involved in the research and development of medicinal cannabis. It offers its products to healthcare professionals and veterinarians. AusCann Group Holdings Ltd is based in West Perth, Australia. Address: 1202 Hay Street, West Perth, WA, Australia, 6005
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ACNNF
Dividend Analytics ACNNF
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ACNNF
Stock Valuation ACNNF
Financials ACNNF
Results | 2019 | Dynamics |